Drug Design - Novel Advances in the Omics Field and Applications 2021
DOI: 10.5772/intechopen.95544
|View full text |Cite
|
Sign up to set email alerts
|

Introductory Chapter: The Emerging Corner of the Omics Studies for Rational Drug Design

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

1
0

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 77 publications
(74 reference statements)
0
1
0
Order By: Relevance
“…As soon as WHO declared the ongoing COVID-19 pandemic in March 2020, several repurposed drugs are prepared. One of them is remdesivir, that previously developed for treating hepatitis C, Ebola, and Marburg virus infections [7][8][9][10][11]. Although there are mixed results in the clinical settings, remdesivir is currently one of the standard options in COVID-19 treatments [12].…”
Section: Current Status Of Covid-19 Drug and Vaccine Developmentmentioning
confidence: 99%
“…As soon as WHO declared the ongoing COVID-19 pandemic in March 2020, several repurposed drugs are prepared. One of them is remdesivir, that previously developed for treating hepatitis C, Ebola, and Marburg virus infections [7][8][9][10][11]. Although there are mixed results in the clinical settings, remdesivir is currently one of the standard options in COVID-19 treatments [12].…”
Section: Current Status Of Covid-19 Drug and Vaccine Developmentmentioning
confidence: 99%